Literature DB >> 8938538

Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.

N K Beinker1, M D Voigt, M Arendse, J Smit, I A Stander, R E Kirsch.   

Abstract

BACKGROUND/AIMS: In hepatitis C, iron depletion may improve serum aminotransferases and the response to interferon, but it is not known whether inflammation and fibrosis correlate with hepatic iron content. Our aim was to establish whether hepatic iron content correlates with histological and serum indices of hepatic inflammation and fibrosis in hepatitis B and C.
METHODS: Total hepatic iron was measured using computerized histomorphometry, and hepatic inflammation and fibrosis using a modified Knodell score, on histological slides from 31 patients with chronic hepatitis B and 38 with hepatitis C.
RESULTS: Total hepatic iron was similar in the hepatitis B and C groups (0.82 +/- 1.72% and 0.56 +/- 1.12%; mean +/- SD). No iron was detectable in 11 patients with hepatitis B and 13 with hepatitis C. Alanine aminotransferase (85.96 +/- 67.1 vs 44.2 +/- 39.7 p < 0.05), aspartate aminotransferase (93.8 +/- 75.6 vs 47 +/- 33.5 IU/ml p < 0.05) and histological inflammatory score (9.33 +/- 3.51 vs 7.79 +/- 3.3 p = 0.07) were increased in those with stainable hepatic iron compared to those without. However, where iron was present, no association was found between the amount of hepatic iron and inflammatory or fibrosis scores. In hepatitis C, fibrosis was minimal in 77% of patients if iron was absent vs 24% with iron present, while marked fibrosis was present in 56% with iron vs 15% without iron (p < 0.01, Fisher's exact test).
CONCLUSION: Hepatic iron is associated with increased hepatic inflammation in chronic hepatitis B and hepatitis C and with high fibrosis scores in hepatitis C. There is a threshold effect, and once present, increasing iron does not correlate with increasing inflammation or fibrosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938538     DOI: 10.1016/s0168-8278(96)80231-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

1.  Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C.

Authors:  Tsung-Jung Lin; Li-Ying Liao; Shyr-Yi Lin; Chih-Lin Lin; Ting-An Chang
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

2.  Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.

Authors:  Suleyman Uraz; Cem Aygun; Abdullah Sonsuz; Gulsen Ozbay
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

3.  The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C.

Authors:  D Thorburn; G Curry; R Spooner; E Spence; K Oien; D Halls; R Fox; E A B McCruden; R N M MacSween; P R Mills
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

4.  Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.

Authors:  Liana Codes; Tarik Asselah; Dominique Cazals-Hatem; Florence Tubach; Dominique Vidaud; Raymundo Paraná; Pierre Bedossa; Dominique Valla; Patrick Marcellin
Journal:  Gut       Date:  2006-09-27       Impact factor: 23.059

5.  Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.

Authors:  Sven G Gehrke; Wolfgang Stremmel; Inge Mathes; Hans-Dieter Riedel; Karin Bents; Birgit Kallinowski
Journal:  J Mol Med (Berl)       Date:  2003-10-14       Impact factor: 4.599

6.  Beneficial effect of phlebotomy on hepatitis C virus-associated musculoskeletal manifestations.

Authors:  N Hilzenrat; D Buskila; D Zilberman; E Sikuler
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

7.  Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients.

Authors:  A El-Zayadi; Osaima Selim; H Hamdy; A El-Tawil; Hanaa-M Badran; M Attia; A Saeed
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

8.  Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.

Authors:  S D Ryder; W L Irving; D A Jones; K R Neal; J C Underwood
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

9.  Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury.

Authors:  Zhaowen Zhu; Anne T Wilson; M Meleah Mathahs; Feng Wen; Kyle E Brown; Bruce A Luxon; Warren N Schmidt
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

10.  Reduced serum hepcidin levels in patients with chronic hepatitis C.

Authors:  Domenico Girelli; Michela Pasino; Julia B Goodnough; Elizabeta Nemeth; Maria Guido; Annalisa Castagna; Fabiana Busti; Natascia Campostrini; Nicola Martinelli; Italo Vantini; Roberto Corrocher; Tomas Ganz; Giovanna Fattovich
Journal:  J Hepatol       Date:  2009-08-12       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.